Clear Search

Showing 1 result for “Huff EE”.

February 2023

Inhibición selectiva de la vía MK2: Datos de un Ensayo de Fase II Aleatorizado Controlado en Artritis Reumatoide

ACR Open Rheumatol. 2023;5(2):63–70 doi: 10.1002/acr2.11517

Data show that the first-in-class MK2 pathway inhibitor ATI-450 was well tolerated and induced sustained anti-inflammatory efficacy over 12 weeks in patients with moderate-to-severe RA.